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Summary
The cyclin-dependent kinase inhibitor p16INK4a (CDKN2A) is an important tumor-suppressor gene
frequently inactivated in human tumors. p16 suppresses the development of cancer by triggering
an irreversible arrest of cell proliferation termed cellular senescence. Here, we describe another
anti-oncogenic function of p16 in addition to its ability to halt cell cycle progression. We show
that transient expression of p16 stably represses the hTERT gene, encoding the catalytic subunit of
telomerase, in both normal and malignant breast epithelial cells. Short-term p16 expression
increases the amount of histone H3 trimethylated on lysine 27 (H3K27) bound to the hTERT
promoter, resulting in transcriptional silencing, likely mediated by polycomb complexes. Our
results indicate that transient p16 exposure may prevent malignant progression in dividing cells by
irreversible repression of genes, such as hTERT, whose activity is necessary for extensive self-
renewal.
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Introduction
The cyclin-dependent kinase (CDK) inhibitor p16INK4a is deleted in ~20% (Sharpless 2005)
and inactivated epigenetically in an additional 20% (Tlsty et al. 2004) of human breast
tumors. The binding of p16 to CDKs 4 and 6 induces conformational changes that disrupt
the interaction of these kinases with D-type cyclins (Pavletich 1999), thus antagonizing
activation of the CDKs. Through inactivation of CDKs 4 and 6, p16 prevents
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phosphorylation and inactivation of the pRb family of cell cycle regulators. This canonical
description, while valid, obscures the p16 function(s) that result in irreversible senescence-
associated changes rather than reversible cell cycle arrest. Using U2OS cells in which the
transcription of p16 was regulated by tetracycline, Dai and Enders (Dai & Enders 2000)
found that induction of p16 for one day arrested most cells in the G1 phase of the cell cycle.
If the inducer was then removed, p16 levels returned to baseline and growth resumed within
3-5 days. If, however, p16 was induced for 6 days, DNA synthesis remained strongly
inhibited and the cells acquired morphological features of senescence. These results
demonstrated that sustained p16 expression is sufficient to impose a stable block to cell
proliferation and that this state becomes independent of p16 expression and
hypophosphorylation of pRb.
The stable effects of p16 may be mediated by chromatin changes. Recent studies have
indicated that p16 can play an active role in the formation of senescence-induced
heterochromatic foci (SAHF) in human cells. Originally characterized in senescent
fibroblasts (Narita et al. 2003), these foci consist of reorganized DNA and are enriched for
proteins normally associated with heterochromatin. The formation of SAHF is slow, taking
several days or weeks, depending on the initiating stimulus, and has been reported to
coincide with the enhanced association of E2F-target promoters with heterochromatin
proteins. Senescent fibroblasts which poorly express p16 and are less stably arrested
(Beausejour et al. 2003), display fewer SAHFs than those that express higher amounts of
p16 (Narita et al. 2006).
In addition to senescence, stable effects of p16 may play a role in differentiation.
Experiments with transgenic mice have demonstrated that p16 deficiency results in an
increased number of hematopoietic stem cells, and is associated with more active cycling
and decreased apoptosis of stem cells under stressful conditions (Janzen et al. 2006). p16
expression has also been linked to decreased self-renewal in neural stem cells (Molofsky et
al. 2006). Increased p16 expression during stem cell differentiation is often associated with
decreased levels of Bmi-1, a polycomb protein required for self-renewal of stem cells
(Molofsky et al. 2003; Liu et al. 2006). Conversely, suppression of p16, either by expression
of Bmi-1 or directly by shRNA or anti-sense methods, is sufficient to immortalize several
types of human epithelial cells (Maurelli et al. 2006; Song et al. 2006), and to extend the life
span of human fibroblasts (Itahana et al. 2003). This may be due, in part, to relaxation of
p16-mediated repression of genes, such as hTERT – encoding the catalytic subunit of
telomerase, necessary for extended or indefinite proliferation.
Results
p16 suppresses hTERT in human mammary epithelial cells (HMEC)
p16 increases progressively in adherent HMEC cultures established from non-malignant
tissues in serum-free medium, resulting in p16-dependent senescence after 10 - 20
population doublings (Fig. 1A,B) (Yaswen & Stampfer 2002). Using sensitive quantitative
PCR-based techniques, we detected significant levels of both telomerase activity and hTERT
mRNA in early passage HMEC (Fig. 1C,D) in agreement with published reports
demonstrating significant telomerase activity and hTERT mRNA in normal breast cells both
in vitro (Belair et al. 1997) and in vivo (Hines et al. 2005). However, telomerase activity and
hTERT mRNA levels decreased rapidly with each passage in culture, reaching negligible
levels within 3 passages. At this stage, most cells in the cultures continued to proliferate,
although, as previously reported (Yaswen & Stampfer 2002), cell proliferation ceased
several population doublings later at passage 5.
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To understand the inverse relationship between p16 and hTERT expression, we silenced p16
expression by RNA interference. We infected HMEC with lentiviruses encoding p16
shRNAs (Beausejour et al. 2003), and achieved significant suppression of p16 expression.
As expected, cultures in which p16 expression was suppressed bypassed the p16-mediated
arrest of cell proliferation, and continued to proliferate exponentially for more than 120
days. Strikingly, cultures with silenced p16 retained significant telomerase activity and
hTERT mRNA, suggesting that p16 is responsible for the passage-dependent decline in
telomerase expression. We verified that this effect of p16 was mediated through pRb family
proteins by employing a retrovirus containing shRNAs directed against pRb, p107, and p130
(Fig. 2). Although compensatory mechanisms (Zhu et al. 1995) prevented repression of
p107 mRNA levels, pRb and p130 mRNAs and protein were significantly reduced using this
construct (Fig 2 A,B), while hTERT mRNA levels and proliferation were maintained (Fig 2
C,D).
Transient expression of p16 leads to stable suppression of telomerase
Because telomerase is a cell cycle regulated enzyme (Belair et al. 1997), the decline in
telomerase expression could be a direct consequence of p16 expression or an indirect
consequence of p16-induced cell cycle arrest. This ambiguity also pertains to reports of
suppressed telomerase activity after enforced expression of p16 in cancer cell lines, such as
MCF7, in which endogenous p16 genes are mutated or non-functional, but the rest of the
pRb pathway is intact (Duan et al. 2004; Saito et al. 2004). To determine whether the ability
of p16 to repress telomerase expression is separable from its growth-inhibitory functions, we
transiently expressed p16 in the telomerase-positive, p16-negative human breast cancer cell
line MDA-MB-231. Cells expressing high levels of tetracycline responsive repressor (tet-R)
protein were infected with lentiviruses expressing p16 under the control of tet-operator
sequences (tet-p16). We induced p16 expression by adding doxycycline (DOX) for 24 h,
after which the cells were extensively washed to remove DOX (Fig 3A). The rise and fall in
p16 expression (Fig. S1) caused transient pRb hypophosphorylation and arrest of cell
proliferation, from which some of the cells recovered and resumed exponential growth (Fig
3B,C). Strikingly, in the cells that recovered growth, transient p16 exposure caused a stable
reduction in telomerase activity that persisted for 29 days (p < 0.084, Student’s t-test) (Fig.
3D), despite exponential growth and the absence of detectable p16 at this time.
Similar results were obtained using another telomerase-positive, p16-negative human breast
cancer cell line, MCF-7. Treatment with DOX for 6, 12, or 24 h caused a rapid rise in p16
expression (Fig. 4A) and a time-dependent, highly significant, repression of telomerase
expression, which then persisted for 55 days (Fig. 4B). Interestingly, p16 exposure resulted
in significant reduction, but not complete suppression of telomerase activity in the MCF7
and MDA-MB-231 breast cancer cells that recovered proliferative potential after DOX
removal, and these mass populations did not undergo telomere crisis. The decrease in
hTERT transcripts in those cells that recovered proliferative potential may not have been
sufficient to suppress the levels of telomerase activity below that required for telomere
maintenance in these cells. Since the majority of the p16-exposed cells did not recover
proliferative potential, it is possible that those tumor cells in which hTERT transcription was
repressed below levels required for telomere maintenance also underwent additional changes
incompatible with continued proliferation.
The above experiments were performed using mass populations of transduced cells, raising
the possibility that the reduction in telomerase activity was due to delayed p16-mediated cell
cycle exit by some cells after DOX removal. We therefore obtained single-cell clones from
an untreated cell population and a population that was exposed to DOX for 26 h. We
expanded the clones for >20 population doublings, and then harvested the cells to measure
telomerase activities (Fig. 4C). While telomerase activity varied in individual clones, clones
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from the population exposed to DOX for 26 h collectively expressed significantly less
telomerase activity than clones from the control population (p < 0.045, Wilcoxon test). At
the time of harvest, no obvious differences in growth were observed in clones expressing
low versus high telomerase activity (Fig. S2). In addition, immunoblotting showed no
differences between high and low telomerase-expressing clones in their low levels of
residual p16 (Fig. 4D). The range of telomerase activities observed in the p16-exposed cells
may be due to differences in viral integration sites and hence differences in the robustness of
the p16 induction. Nevertheless, these results clearly demonstrate that the hTERT-inhibitory
function of p16 is irreversible and does not require maintenance of p16 expression.
To explore the possibility that p16-mediated suppression of hTERT expression might be
attributable to changes in diffusible transcription factors, such as E2Fs, which are down-
stream of pRb-family proteins, and have been previously shown to down regulate telomerase
(Crowe et al. 2001; Won et al. 2002), we analyzed hTERT promoter activity. We chose high
(0-2, 0-4) telomerase expressing clones from the untreated MCF7 population and low (26-1,
26-5) telomerase-expressing clones from a population exposed to DOX for 26 h. We
transiently transfected the cells with plasmids containing different segments of the human
hTERT promoter linked to a luciferase reporter gene. No significant differences were
observed in hTERT promoter activities between the high and low telomerase-expressing
clones (p > 0.2, Wilcoxon test for all reporter plasmids) (Fig. 4E). In addition, cells arrested
by prolonged (48 hr) p16 exposure exhibited only minor (< 2-fold) while significant
decreases in hTERT promoter activities (Fig. S3). Thus, in this system, repression of
telomerase activity following p16 induction is not due to loss or gain of diffusible
transcriptional activators/repressors of the proximal hTERT promoter, suggesting instead
that chromatin modifications at the endogenous locus may alter its accessibility.
The hTERT gene and 5’ flanking sequences are located in a CpG island. However, attempts
to correlate the methylation status of these regions with hTERT expression have yielded
ambiguous results (Devereux et al. 1999). We examined two regions of the hTERT CpG
island previously shown to undergo differential methylation and to contain transcriptional
regulatory elements (Renaud et al. 2007). One region contains the core promoter that is
necessary for hTERT expression; the other is the exonic region where the CTCF repressor
binds. We analyzed the DNA methylation status of these regions in p16-exposed and control
MCF7 clones, but found no obvious correlations between DNA methylation and telomerase
activity (Fig. S4).
p16 induction results in increased methylation of lysine 27 on histone H3 associated with
hTERT sequences
To determine whether p16 suppresses telomerase expression by modifying chromatin
composition, we assayed the relative levels of specifically modified histones bound to the
hTERT gene before and after p16 exposure. MCF7 cells were harvested immediately
following 48 h exposure to DOX, or were treated with DOX for 24 h and allowed to recover
and proliferate for 10-14 d before being harvested. As expected, transient p16 induction
resulted in stable suppression of hTERT mRNA levels (Fig. 5A). We then performed
chromatin immunoprecipitation (ChIP) with lysates from untreated or DOX-treated cells, as
well as cells allowed to recover after DOX treatment, using specific antibodies against
histone H3 with trimethylated lysine 27 (H3K27), or lysine 9 (H3K9); histone modifications
generally associated with gene silencing (Berger 2007). Multiple sequences in both the
hTERT promoter and protein-coding regions were examined (Fig 5B). Following p16
induction for 48 h, there were significant increases in the levels of hTERT sequences bound
by H3K27 (Fig. 5C), indicating that H3 histones in this chromatin region underwent
widespread K27 methylation. In cells exposed to p16 for just 24 h and allowed to recover
proliferative potential, the magnitude and extent of H3K27 methylation were more limited,
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but still significantly greater than in unexposed cells (Fig. 5D). Similar results were obtained
in MDA-MB-231 cells (Fig. S5). In contrast, little change occurred in the levels of hTERT
sequences bound by H3K9 in DOX treated samples (Fig. S6). MDA-MB-231 cells allowed
to recover, however, exhibited significant increases in hTERT sequences bound by H3K9,
suggesting that H3K9 methylation may play a role in maintaining the long-term epigenetic
effects of p16 exposure.
To determine whether p16 triggers epigenetic alterations throughout the genome, we used
ChIP-enriched DNA to probe the binding of ENCODE regions (Birney et al. 2007) to
modified histones prior to, during, or after induction of p16 expression in MCF7 cells. A
significant reduction was observed in the number of sequences bound by H3K27 following
p16 induction (Fig. S7), in agreement with previous reports (Bracken et al. 2007).
Interestingly, the reduction in regions bound by H3K27 persisted after removal of DOX.
Taken together with the concurrent increases we have observed in H3K27 bound by hTERT
promoter sequences, these results suggest that H3K27 methylation is not simply reduced,
but is stably redistributed following p16 induction.
Finally, to determine if the local increase in H3K27 bound to the hTERT promoter in p16-
exposed cells is accompanied by an increase in EZH2, a histone methylase commonly
associated with H3K27 methylation, we performed similar ChIP experiments using an
EZH2-specific antibody (Fig. S8). Levels of EZH2 associated with the hTERT locus after
p16 exposure were generally decreased rather than increased, suggesting that the local
increase in H3K27 bound to the hTERT gene in p16-exposed cells is mediated by an
alternative histone methylase.
Discussion
We propose that p16-mediated suppression of telomerase is a novel tumor-suppressing
mechanism that is likely to be important in epithelial tissues that retain significant
telomerase activity in adulthood. In agreement with this hypothesis, p16 suppression
resulted in increased telomerase activity and significantly extended proliferative potential in
cultured HMEC.
Our finding that transient induction of p16 has irreversible consequences may also explain
its recently demonstrated role in decreasing the self-renewal potential of adult stem cells
(Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006). Because limited p16
exposure can suppress telomerase without irreversibly affecting reentry into the cell cycle, it
is possible that p16 plays a key role in the differentiation of telomerase-positive stem or
progenitor cells into telomerase-negative cells that are capable of limited proliferation, and
therefore are less susceptible to malignant transformation. In agreement with this model,
embryonic stem (ES) cells contain constitutively hyperphosphorylated pRb and p107
proteins (Galderisi et al. 2006), and an inactive p16 pathway, which only begins to function
at the onset of differentiation (White et al. 2005). In vivo, p16 induction occurs during
mammary involution in rodents (Gadd et al. 2001). Such induction may suppress expression
of genes involved in self-renewal in epithelial cells that remain after involution, thereby
limiting their proliferation and protecting them from oncogenic transformation. This may
explain why full term pregnancy is associated with reduced risk of breast cancer in humans
(Kelsey et al. 1993).
p16-mediated heterochromatin formation during cellular senescence may involve activation
of partial or aberrant differentiation programs. In fact, on the basis of morphological and
functional features, it was argued over a decade ago that p16 induction at senescence is due
to initiation of differentiation in senescent cells (Stein et al. 1999). Conversely, pRb-
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mediated transcriptional repression observed during senescence is also likely to be involved
in terminal differentiation. For example, pRb-dependent histone H3K27 methylation of cell
cycle genes has recently been reported in irreversibly arrested myotubes, but not reversibly
quiescent murine embryo fibroblasts (Blais et al. 2007).
The H3K27 chromatin mark has been associated with the histone methyltransferase activity
of PRC2 polycomb repressor complexes (reviewed in (Kanno et al. 2008)). These
developmentally regulated multimeric transcriptional repressor complexes are structurally
and functionally diverse in mammalian cells. In general, trimethylation of H3K27 by PRC2
complexes is thought to cause the recruitment of PRC1 complexes, resulting in stable
repression of target genes. ES cell differentiation is associated with widespread changes in
the binding of PRC complexes (Boyer et al. 2006; Lee et al. 2006), as well as reduced
hTERT expression, at least partly via epigenetic mechanisms (Wang et al. 2007).
Since trimethylated H3K27 is redistributed in breast cancer cells exposed to p16, and is
ordinarily bound by PRC1 (Cao et al. 2002), it is likely that PRC complexes are also
redistributed following p16 induction. In agreement with our findings, p16 induction has
been found to increase binding of HPC2 (Cbx5) - a component of PRC1, to the cyclin A
promoter in U2-OS cells (Dahiya et al. 2001). H3K27 is methylated by PRC2 component
EZH2 (Kuzmichev et al. 2002). p16-mediated activation of pRb leads to reduction of EZH2
(Bracken et al. 2003), resulting in global reduction of H3K27. Interestingly, although PRC2
is responsible for H3K27 methylation in growing ES cells, two core components of the
canonical PRC2 complex, Suz12 and EZH2, were not detected at the targets of pRb
silencing in differentiated myotubes, raising the possibility that multiple distinct complexes
may possess H3K27 histone methylase activity involved in targeting pRb-regulated genes
(Blais et al. 2007). Similarly, we determined that the local increase in H3K27 bound to the
hTERT gene in p16-exposed cells was not accompanied by increased EZH2, suggesting the
involvement of an alternative histone methylase. Further determination of the cellular
components that mediate p16-initiated silencing of genes such as hTERT may be useful in
the design of strategies to compensate for the loss of the tumor suppressor, and stop the self-
renewal of cancer-initiating cells.
Experimental procedures
Cell culture
HMEC were obtained from histologically normal reduction mammoplasty or prophylactic
mastectomy tissues (UCSF Comprehensive Cancer Center Tissue Core) and grown in
MEGM medium (Lonza, Walkersville, MD, USA). MDA-MB-231 and MCF7 cells were
obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and
cultured in DMEM with 10% fetal bovine serum (Tet System Approved FBS, Clontech,
Mountain View, CA, USA).
Plasmids
Inducible expression of p16 was accomplished by inserting a p16 cDNA (Beausejour et al.
2003) in front of the DOX-inducible promoter of the pLenti CMV/TO Puro DEST (670-1)
vector (Campeau et al. 2009). A retrovirus encoding pRB, p107, and p130 shRNAs (Chicas
et al.) was generated in the LMP vector (Thermo Scientific, Huntsville, AL, USA).
Immunoblotting
Total protein lysates were collected and processed for immunoblotting by standard methods.
Prominent Ponceau-stained protein bands were used as loading controls. Antibodies used
included those against p16 (Ab-1; NeoMarkers, Fremont, CA, USA), total-pRb (05-377,
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Upstate Biotech., Lake Placid, NY, USA), phospho-pRb Ser 807/811 (9308, Cell Signaling,
Beverly MA, USA), phospho-pRb Ser 795 (9301, Cell Signaling), p107 (sc-318, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), and p130 (sc-317, Santa Cruz Biotechnology).
Telomerase
Telomerase activity was measured using a commercial assay (Allied Biotech, Ijamsville,
MD, USA) according to the manufacturer’s instructions. Relative levels of hTERT mRNA
were quantitated using a real-time PCR assay (Hines et al. 2005).
Reporter Assays
pGL3-3396, pGL3-996 and pGL3-179 plasmids containing 3396, 996 or 179 base pair
fragments upstream of the hTERT gene (Oh et al. 1999) in pGL3 (Promega, Madison, WI,
USA) were provided by Dr. Tae Kook Kim (Korea Advanced Institute for Science and
Technology). The plasmids were transfected into MCF7 clones using FuGene 6 (Roche,
Indianapolis, IN, USA), and luciferase activities were determined 48 hours after transfection
using the Dual Luciferase Assay (Promega).
DNA methylation analyses
Genomic bisulfite sequencing of the promoter and first exon of hTERT was performed as
previously described (Renaud et al. 2007).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation was performed as previously described (Kim et al. 2005).
Briefly, cells were cross-linked with 1% methanol-free formaldehyde for 10 min. at room
temperature, followed by quenching with 0.125M glycine for 5 min. Following washes, cells
were resuspended in lysis buffer at concentrations of 1 × 107 cells per 0.5 ml. Chromosomal
DNA was disrupted using an Ultrasonic Liquid Processor (MISONIX, Inc., Farmingdale,
NY, USA). The sizes of DNA fragments obtained were determined by agarose gel
electrophoresis with a 200-1000 base pair range considered acceptable. Immunoprecipitation
was performed overnight using antibodies obtained from commercial sources: (H3K27me3,
Upstate 07-449; H3K9me3, Abcam (Cambridge, MA, USA) ab8898; EZH2, Abcam
ab3748) followed by 1 hr incubation with pre-blocked Protein-A or -G conjugated
Dynabeads (Invitrogen, Carlsbad, CA, USA). Following washes, reversal of cross-linking
and proteinase K treatment, enriched DNAs were purified using QIAquick PCR purification
kits (Qiagen, Valencia, CA, USA). Each experiment included IgG and beads-only negative
controls. The relative amounts of targeted sequences bound to the immunoprecipitated
material were determined by quantitative PCR and normalized to the amounts of β-actin
sequences bound.
hTERT and β-actin promoter PCR
Primers for hTERT promoter and coding region amplification are described (Table S1).
Primers for β-actin were F: aaatgctgcactgtgcggcgaa, R: tgctcgcgggcggacgcggtctcgg.
Quantitative PCR was performed using a commercial kit (Finnzymes, Woburn, MA, USA).
pRb family qRT-PCR
Primers for pRb, p107, p130, and stably expressed reference gene, TBP (TATA box binding
protein; NM_003194) transcript quantification are described (Table S2). Quantitative RT-
PCR was performed using a commercial kit (SYBR GreenER kit, Invitrogen, CA, USA)
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ChIP/CHIP
Amplification, labeling, and hybridization were performed as previously described (Kim et
al. 2005). Briefly, blunt ends were created on ChIP-enriched DNA with T4 DNA
polymerase (New England Biolabs, Beverly, MA, USA). The DNA was then ligated to
linkers (oJW102, 5-GCGGTGACCCGGGAGATCTGAATTC-3; oJW103, 5-
GAATTCAGATC-3) and subjected to ligation-mediated PCR. Amplified DNA was labeled
with fluorescent Cy3 and Cy5 dCTP (95040-166, VWR, Brisbane, CA, USA) using a
BioPrime Array CGH labeling system (18095012, Invitrogen, Carlsbad, CA, USA). Equal
amounts of Cy3 (Input) and Cy5 (ChIP) labeled DNA were hybridized to custom ENCODE
arrays. Hybridization and washing of the arrays were performed using of a TECAN HS 4800
Pro Hybridization Station (Tecan, San Jose, CA, USA). Array data was normalized using
median normalization following background correction. Enrichment was calculated relative
to input genomic DNA extracted from sonicated chromatin. The average enrichment ratio
for each array probe was calculated for triplicate experiments and deemed significant for
those elements with P<0.001. GEO accession numbers GSM359288 – 359314.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
p16INK4a is responsible for telomerase repression in proliferating HMEC. (A) Control and
corresponding cultures expressing p16shRNA were harvested at indicated passages (p).
Total p16 levels were determined by immunoblotting. (B) Total population doublings of
control HMEC or HMEC expressing shp16 are plotted versus time. Results shown are
representative of 4 non-malignant specimens. (C) Telomerase activity was assayed at
indicated passages. Mean values and SD (n=3) are representative of two non-malignant
specimens. Values significantly different from telomerase activity at passage 2 (p < 0.05,
Student’s t-test) are denoted with a *. (D) hTERT mRNA levels were assayed at indicated
passages by Taqman PCR. Mean values and SD (n=6) are representative of two non-
malignant specimens and presented relative to each other after normalization using mRNA
levels of TATA binding protein (TBP). Values significantly different from hTERT mRNA
levels at passage 1 (p < 0.05, Student’s t-test) are denoted with a *. Values obtained for
normal human fibroblasts (WI38) and malignant human breast cancer cells (MCF7) are
presented as negative and positive controls.
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Fig. 2.
Telomerase repression in HMEC is mediated by pRb-family proteins. (A) Relative levels of
pRb, p107, and p130 mRNAs in HMEC stably transduced at passage 2 with a control vector
or a vector encoding shRNAs against these three transcripts were determined by quantitative
RT-PCR. Mean values and SD (n=3) are shown. Values significantly different from controls
(p < 0.05, Student’s t-test) are denoted with a *. (B) HMEC expressing shRb/107/130,
shp16, or vector controls were harvested and pRb, p107, p130 and p16 levels were
determined by immunoblotting. (C) Total population doublings of HMEC expressing shRB/
107/130, shp16, or control viruses are plotted versus time. (D) hTERT mRNA levels were
assayed at passage 5 by Taqman PCR. Mean mRNA levels ± SD (n=3) are presented
relative to each other after normalization using mRNA levels of TATA binding protein
(TBP).
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Fig. 3.
Transient expression of p16 leads to stable repression of telomerase in MDA-MB-231 cells.
(A) Scheme of experimental design. (B) Following 24 hr incubation with or without
doxycycline, MDA-MB231-tetR-tet-p16 cells were maintained in culture and propagated
when confluent. Total population doublings are plotted versus days in culture. (C) p16 and
phospho-pRb expression at times indicated were determined by immunoblotting. Results
shown for “No Induction” and “p16 Pulse” were obtained from the same gel. (D)
Telomerase activity was determined in control and doxycycline-treated MDA-MB231-tetR-
tet-p16 cells harvested at times indicated. Mean values and SD (n=3) are shown.
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Fig. 4.
Time-dependent repression of telomerase activity following p16 induction is not due to loss
or gain of diffusible transcriptional activators/repressors. (A) MCF7-tetR-tetp16 cells were
treated with doxycycline for times indicated and harvested. p16 levels were determined by
immunoblotting. (B) MCF7-tetR-tetp16 cells were treated with doxycycline for times
indicated and grown under normal conditions. The cultures were divided when sub-
confluent. At days 1 and 55 of the experiment, the cells were harvested and telomerase
activity was determined. Mean values and standard deviations are shown (n=3). Values
significantly different from the untreated control (p < 0.05, Student’s t-test) are denoted with
a *. (C) MCF7-tetR-tetp16 cells were treated with doxycycline for 26 hours, seeded at clonal
densities and expended into cell lines. Six doxycycline treated clones and 6 control clones
were analyzed for telomerase activity. Arrows indicate telomerase activity in clones used in
subsequent experiments. (D) p16 expression levels in MCF7-tetR-tetp16 clones were
determined by immunoblotting. Negative control: parental MCF7; positive control: MDA-
MB468. (E) Indicated cells were transfected with plasmids encoding luciferase under the
control of hTERT promoter sequences of indicated lengths. hTERT promoter activity was
measured and normalized to that of a co-transfected promoterless Renilla construct. Mean
values and standard deviations are shown (n=3).
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Fig. 5.
p16 expression causes increased histone H3-K27 methylation of hTERT promoter and
protein coding sequences. (A) hTERT mRNA levels in MCF7-tetR-tetp16 cells. Mean values
and standard deviations are shown (n=3). U, untreated cells; T, cells treated with
doxycycline for 48 hours; R, cells treated with doxycyline for 24 hours when 10-15%
confluent, allowed to recover and harvested when sub-confluent. T and R values
significantly different from U (p < 0.05, Student’s t-test) are denoted with a *. (B) Map of
the hTERT promoter and protein coding regions with PCR amplification targets indicated by
letters A through P. (C & D) Chromatin immunoprecipitations were performed with
antibodies that specifically recognize trimethylated H3K27. The relative amounts of hTERT
sequences bound to the immunoprecipitated material were determined by quantitative PCR
and normalized to the amounts of β-actin sequences bound. Mean values and standard
deviations are shown (n=3). T and R values significantly different from U (p < 0.05,
Student’s t-test) are denoted with a *.
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